Monoclonal antibodies have been developed which necessitate revision of the optimal composition of anti-human globulin reagents. For example, because of the limitations imposed by the presence of C3d on normal red cells, particularly in stored blood, conventional polyclonal anti-complement reagents rely on anti-C3c to detect in vitro bound complement and limited amounts of anti-C3d to detect in vivo bound complement. However, some monoclonal IgM anti-C3d reagents can be used at concentrations adequate to detect both in vitro and in vivo bound complement without causing unwanted positive reactions with normal red cells and fresh, inert, group-compatible serum in routine tests., If cross-reactivity is observed then a different blocker should be tested and if repeated cross-reactivity is observed it may be advisable to switch to a non-mammalian protein blocker such as salmon serum or a protein free blocking solution. Visit our website for more information on our wide selection of ready-to-use blocking buffers., Each kit is developed and verified to optimally perform with the included reagents and according to protocol recommendations. Combining kits can risk antibody cross-reactivity, incompatible sample dilution factors, inappropriate serum matrix, buffers, or incubation periods – any of which can skew your results..